{"data":{"ModuleTitle":{"label":"Module Title","value":"Company Description"},"CompanyName":{"label":"Company Name","value":"Lantern Pharma Inc."},"Symbol":{"label":"Symbol","value":"LTRN"},"Address":{"label":"Address","value":"1920 MCKINNEY AVENUE,7TH FLOOR, DALLAS, Texas, 75201, United States"},"Phone":{"label":"Phone","value":"+1 972 277-1136"},"Industry":{"label":"Industry","value":"Biotechnology: Pharmaceutical Preparations"},"Sector":{"label":"Sector","value":"Health Care"},"Region":{"label":"Region","value":"North America"},"CompanyDescription":{"label":"Company Description","value":"Lantern Pharma Inc is a clinical-stage biotechnology company. It is focused on leveraging artificial intelligence (A.I), machine learning and genomic data to streamline the drug development process and to identify the patients that will benefit from targeted oncology therapies. The firm's pipeline of development programs involves four drug candidates and an Antibody Drug Conjugate (ADC) program directed towards eight therapeutic targets. Its A.I. platform, known as RADR, includes more than 18 billion data points, and uses big data analytics and machine learning to rapidly uncover biologically relevant genomic signatures correlated to drug response, and then identify the cancer patients that we believe may benefit most from our compounds."},"CompanyUrl":{"label":"Company Url","value":"https://www.lanternpharma.com"},"KeyExecutives":{"label":"Key Executives","value":[{"name":"Ernest Kitt","title":"Head-Clinical Operations"},{"name":"Kishor G. Bhatia","title":"Chief Scientific Officer"},{"name":"Panna L. Sharma","title":"President, Chief Executive Officer & Director"},{"name":"Reggie Ewesuedo","title":"Vice President-Clinical Development"}]}},"message":null,"status":{"rCode":200,"bCodeMessage":null,"developerMessage":null}}